| Amelogenesis Research Group |
The group aims to understand tooth, and specifically enamel, formation and function by studying conditions such as amelogenesis imperfecta, an inherited failure of enamel development. |
| Brain Cancer Research Group |
We are a consortium of investigators working to understand the processes that promote the development of different brain cancers, translating our findings for the benefit of brain cancer patients. |
| Breast Cancer Research Group |
We are a multidisciplinary and cross-faculty grouping working on all aspects of breast cancer in an effort to improve understanding of the disease. Our key aims are to identify strategies to prevent breast cancer, develop new treatments for breast cancer, and translate our research findings so that more patients can live beyond breast cancer, with improved quality of life. |
| Cancer Epidemiology Group |
Led by Dr Amy Downing, the Cancer Epidemiology Group uses large scale datasets to research cancer, particularly bowel cancer. The group has extensive experience of using routine, NHS datasets to inform screening, treatment and service planning. |
| Cancer Survivor Intelligence Group |
The Cancer Survivor Intelligence (CSI) Group is led by Professor Adam Glaser and focuses on the collection of information from individuals living with and beyond cancer in order to generate enhanced intelligence on the consequences of cancer survival. |
| Epidemiology and Biostatistics |
The Section of Epidemiology and Biostatistics brings together biologists, laboratory scientists, clinicians, psychologists, epidemiologists, biostatisticians and statisticians to develop, conduct and interpret research studies. We have a particular interest in cancer research. |
| Healthcare Associated Infection Research Group |
Our group's research projects are diverse, including multiple aspects of Clostridium difficile infection, including pathogenesis, epidemiology, diagnosis, treatment and prevention, infection diagnostics, antibiotic resistance and the gut microbiome, staphylococcal and intra-abdominal infections, and the clinical development of new antimicrobial agents. |
| Infection and Immunity Group |
The Infection and immunity group investigates these phenomena at the molecular level aiming to exploit our findings in the understanding and treatment of human diseases. Our research encompasses virology, structural biology, immunology, cancer biology and immunotherapy. |
| Oncolytic Virus Research Group |
We are a group of research scientists studying oncolytic virotherapy for the treatment of cancer. We aim to identify the best strategies for maximizing the therapeutic benefit of oncolytic viruses by potentiating both the direct oncolytic and tumour-specific, immune-mediated effects of these viruses and to translate our findings into the clinic for the benefit of patients. |
| Pathology and Data Analytics |
The Division of Pathology and Data Analytics is a fusion of academic pathology with data analytics teams to allow us to fully understand the importance of pathology/data advances to patient outcomes. We undertake translational research across a number of different types of cancer e.g. bowel, oesophageal, gastric, gynaecological and head and neck as well as in digital pathology/artificial intelligence, molecular pathology, embryology, cardiovascular disease and the microbiome in health and disease. Data is fundamental to understanding human behaviours in populations and medicine and driving translational science with data science expertise in bowel cancer, nutrition, molecular epidemiology and liver disease. Data scientists are critical to the future of the Division. We undertake pathology undergraduate and post graduate education and conduct translational research and support disease prevention, screening and treatment through clinical trials/studies to improve patient outcomes, including the application of new cutting edge technologies. |
| Perinatal Research Group |
The group's work covers a range of themes ranging from understanding disease aetiology through to the application of our findings in translational clinical trials. |
| Section of Patient Centred Outcomes Research |
Our section focuses its research in several areas, with the common aim of using Patient Reported Outcome Measures (PROMS) to improve quality of life and patient-centred care. |
| The Melanoma Research Group |
The Melanoma Research Group uses genetic epidemiology to understand why people get melanoma and what determines survival after diagnosis. |
| The Radiotherapy Research Group |
We deliver internationally leading, patient focused, radiotherapy research that improves cancer outcomes and reduces side effects. We are a multidisciplinary research team with expertise ranging from pre-clinical radiation biology through to phase III clinical trials. Tumour site interests include gastrointestinal, brain, urological and lung cancers. |
| Vision Research Group |
The Vision Research Group uses a variety of approaches to study diseases of the eye and of vision. |
